Blood neurofilament light chain as a surrogate marker for dystonia

Background and purpose: Dystonia is a heterogeneous movement disorder, and it remains unclear whether neurodegeneration is involved. Neurofilament light chain (NfL) is a biosignature of neurodegeneration. We aimed to investigate whether plasma NfL levels were elevated and associated with disease severity in patients with dystonia. Method: We enrolled 231 unrelated dystonia patients (isolated dystonia n = 203; combined dystonia n = 28) and 54 healthy controls from movement disorder clinics. Clinical severity was evaluated using the Fahn Marsden Dystonia Rating Scale, the Unified Dystonia Rating Scale, and the Global Dystonia Rating Scale. Blood NfL levels were measured by single-molecule array. Results: Plasma NfL levels were significantly higher in those with generalized dystonia compared to those with focal dystonia (20.1 +/- 8.8 vs. 11.7 +/- 7.2 pg/mL; p = 0.01) or controls (p < 0.01), while the level was comparable between the focal dystonia group and controls (p = 0.08). Furthermore, the dystonia combined with parkinsonism group had higher NfL levels than the isolated dystonia group (17.4 +/- 6.2 vs. 13.5 +/- 7.5 pg/mL; p = 0.04). Notably, whole-exome sequencing was performed in 79 patients and two patients were identified as having likely pathogenic variants: one had a heterozygous c.122G>A (p.R41H) variant in THAP1 (DYT6) and the other carried a c.1825G>A (p.D609N) substitution in ATP1A3 (DYT12). No significant correlation was found between plasma NfL levels and dystonia rating scores. Conclusion: Plasma NfL levels are elevated in patients with generalized dystonia and dystonia combined with parkinsonism, suggesting that neurodegeneration is involved in the disease process of this subgroup of patients.

Automated summary

This study aimed to investigate whether plasma NfL levels were elevated and associated with disease severity in patients with dystonia. The results showed that plasma NfL levels were significantly higher in those with generalized dystonia compared to those with focal dystonia or controls, while the level was comparable between the focal dystonia group and controls. Furthermore, the dystonia combined with parkinsonism group had higher NfL levels than the isolated dystonia group. This suggests that neurodegeneration is involved in the disease process of this subgroup of patients.